Related Experiment Video
Updated: Nov 10, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Pitfalls when comparing COVID-19-related outcomes across studies-lessons learnt from the ERACODA collaboration
Marlies Noordzij1, Priya Vart1,2, Raphaël Duivenvoorden3
1Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Abstract:
Reported outcomes, such as incidence rates of mortality and intensive care unit admission, vary widely across epidemiological coronavirus disease 2019 (COVID-19) studies, including in the nephrology field. This variation can in part be explained by differences in patient characteristics, but also methodological aspects must be considered. In this review, we reflect on the methodological factors that contribute to the observed variation in COVID-19-related outcomes and their risk factors that are identified in the various studies. We focus on issues that arose during the design and analysis phase of the European Renal Association COVID-19 Database (ERACODA), and use examples from recently published reports on COVID-19 to illustrate these issues.
Related Concept Videos
Bias in Epidemiological Studies
Confounding in Epidemiological Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Causality in Epidemiology
Bioavailability Study Design: Healthy Subjects Versus Patients

